Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02664922 · ClinicalTrials.gov registry record · Phase 4
Anesthetic Techniques in EP Patients
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT02664922: Clinical Trial Phase 4 study, sponsored by University of California, Los Angeles.
NCT02664922 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 35 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02664922, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to compare different combinations of anesthetic drugs (cause loss of sensation) in terms of effectiveness, adverse effects, pain relief, and patient comfort for cardiac electrophysiology procedures. In addition, the investigators are studying the different anesthetic combinations to determine the best approach in terms of identification and treatment of arrhythmias.
Primary Outcome
Direct observation and medical record review will be used to analyze adverse effects. Reported as number of participants with one or more adverse events.
Interventions
- DRUG Ketamine
- DRUG Sevoflurane
- DRUG Propofol
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Why NCT02664922 stopped before completion
NCT02664922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT02664922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02664922 about?
NCT02664922 is a clinical study titled "Anesthetic Techniques in EP Patients". The purpose of this study is to compare different combinations of anesthetic drugs (cause loss of sensation) in terms of effectiveness, adverse effects, pain relief, and patient comfort for cardiac electrophysiology procedures. In addition, the investigators are studying the different anesthetic com...
What is the current status of trial NCT02664922?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2012-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02664922?
The interventions under investigation include: Ketamine (DRUG), Sevoflurane (DRUG), Propofol (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02664922?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02664922's enrollment target sits among peer trials
35 1506th of 2000 higher than 481 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia